Steering Group

Home Introduction Survey News Steering Group Stakeholders FAQS Contact

The Steering Group is responsible for co-ordinating and organising the various

stages in the priority setting process. The group has an independent Chair,

Leanne Metcalf from the James Lind Alliance (JLA). Leanne is responsible for

facilitating the process, ensuring that it follows the JLA principles of transparency

with equal involvement of patients, carers and clinicians. Please feel free to

contact members of the steering group with queries regarding the PSP.

Steering Group Members Leanne Metcalf, JLA Alexander Heazell, Senior Clinical Lecturer in Obstetrics, Maternal and Fetal Health Research Centre, University of Manchester Charlotte Bevan, Senior Research and Prevention Advisor Sands, the stillbirth and neonatal death charity Jane Brewin. Chief Executive, Tommy’s - Independent Carer Representative Catherine Calderwood. Consultant Obstetrician and Gynaecologist. NHS England Andrew Canter, Chairman, National Maternity Support Foundation (NMSF) Flora Jessop, Consultant Pathologist, Royal College of Pathologists Gail Johnson, Royal College of Midwives, Professional Advisor Education Isobel Martin. The Holly Martin Stillbirth Research Fund Melissa K Whitworth. Consultant Obstetrician, British Maternal and Fetal Medicine Society
Info Info Info Info Info Info Info Info Info
The James Lind Alliance (JLA) is a non-profit-making initiative, established in 2004. It brings patients, carers and clinicians together in  Priority Setting Partnerships (PSPs), the aim of which is to identify and prioritise uncertainties, or ‘unanswered questions’, about the effects  of treatments and interventions in different health conditions, topics or settings. The purpose of this is to ensure that those who fund and  carry out health research are aware of what research questions really matter to both patients and clinicians. In turn, this helps to  encourage clinical research that is relevant, beneficial and addresses questions that are of practical importance to those directly affected. The JLA believes that: addressing uncertainties about the effects of treatments or interventions should become accepted as a much more routine part of  clinical practice patients, carers and clinicians should work together to agree which, among those uncertainties, matter most and thus deserve  priority attention. The JLA is funded by the National Institute for Health Research (NIHR) and is coordinated through the NIHR Evaluation, Trials and Studies  Coordinating Centre (NETSCC). To find out more about current and past PSPs, please visit www.jla.nihr.ac.uk. You can also find out more  by reading the information leaflet JLAInfo for further information about the JLA.
Info
© 2014 stillbirthpsp Privacy Terms of Use Design by Technology Framework
Steering Group